Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists track Long-Term protection of mom & baby vaccine

NCT ID NCT06592586

Summary

This study follows up with healthy pregnant women who previously received an investigational vaccine against Group B Streptococcus (GBS). The main goal is to see how long their immune protection lasts. It will also test the safety and immune response when some participants receive a booster dose of the vaccine during a new pregnancy.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aarhus Universitetshospital

    RECRUITING

    Aarhus N, Central Jutland, 8200, Denmark

  • Hvidovre Hospital - Department Of Obstetrics And Gynaecology

    ACTIVE_NOT_RECRUITING

    Copenhagen, Capital Region, 2650, Denmark

  • Sefako Makgatho Health Sciences University, Medunsa Clinical Research Unit (MeCRU)

    RECRUITING

    Ga-Rankuwa, Gauteng, 0204, South Africa

  • Setshaba Research Centre

    RECRUITING

    Pretoria, Guateng Province, 0152, South Africa

  • Sygehus Lillebælt - Kolding Sygehus

    RECRUITING

    Kolding, Region Syddanmark, 6000, Denmark

  • Wits Reproductive Health and HIV Institute (Wits RHI)

    RECRUITING

    Johannesburg, Guateng Province, 2001, South Africa

Conditions

Explore the condition pages connected to this study.